Alzheimer’s Dementia

Alzheimer’s dementia is the most common type of dementia in the U.S., according to the Centers for Disease Control and Prevention. Current estimates are that about 5.8 million people have Alzheimer’s and related dementias. By 2060, the number of people with Alzheimer’s dementia is predicted to be 14 million. Health conditions like diabetes, hypertension and other co-morbidities are often associated with dementia (per CDC). People with a family history, have a higher likelihood of getting it. The alarming increase has been in those aged 40s to 60s.

Alzheimer’s dementia is, unfortunately, a very debilitating disease associated with declining memory that starts a good 10 to 15 years before a diagnosis is established. Once diagnosed, the decline varies, with some rapidly progressing while others take a longer course. Not only does it take a toll on the patient, but also on caregivers, both emotionally, and financially.

However, with a functional medicine approach, it is possible to reverse Alzheimer’s by finding out the root cause and correcting the imbalances. Dr. Dale Bredesen, a neurologist, and professor at UCLA has been researching the treatment, prevention, and reversal of this disease. He has published his research, written books on the reversal of cognitive decline, and runs a training program for practitioners.

Under his training and certification, we will be offering our ReCode 2.0 (REversal of COgnitiveDEcline) program.

Early to mild Alzheimer’s and those with a family history, for prevention, can be treated more effectively, than someone who has already declined considerably.

References: Review J Alzheimer’s Disease. 2020;78(2):853-854. doi: 10.3233/JAD-201157.

The End of Alzheimer’s Protocol:

The First Protocol to Enhance Cognition and Reverse, Decline at Any Age by Dale Bredesen, Avery, 2020, 352 pp

DharJAD-201157ma Singh Khalsa 1Affiliations expandPMID: 33074243 DOI: 10.3233/